A review of the Knops blood group: separating fact from fallacy

1Daniels GL, Anstee DJ, Cartron J-P, et al. International Society of Blood Transfusion working party on terminology for red cell surface antigens. Vox Sang 2001;80:193-6.10.1046/j.1423-0410.2001.00024.x11449960Search in Google Scholar

2Giles CM, Huth MC, Wilson TE, Lewis HBM, Grove GEB. Three examples of a new antibody, anti-Cs^a, which reacts with 98% of red cell samples. Vox Sang 1965;10:405-15.10.1111/j.1423-0410.1965.tb04354.x5851803Search in Google Scholar

3Moulds JM, Nickells MW, Moulds JJ, Brown MC, Atkinson JP. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-Langley, and York blood group sera. J Exp Med 1991;173:1159-63.10.1084/jem.173.5.115921188661708809Search in Google Scholar

4Petty AC, Green CA, Poole J, Daniels GL. Analysis of Knops blood group antigens on CR1 (CD35) by the MAIEA test and by immunoblotting. Transfus Med 1997;7:55-62.10.1046/j.1365-3148.1997.d01-71.x9089986Search in Google Scholar

5Helgeson M, Swanson J, Polesky HF. Knops-Helgeson (Kn^a), a high frequency erythrocyte antigen. Transfusion 1970;10:737-8.10.1111/j.1537-2995.1970.tb00720.x4192883Search in Google Scholar

6Molthan L, Giles CM. A new antigen, Yk^a, and its relationship to Cs^a (Cost). Vox Sang 29:1975;145-53.10.1159/000465437Search in Google Scholar

7Molthan L, Moulds J. A new antigen, McC^a (McCoy), and its relationship to Kn^a (Knops). Transfusion 1978;18:566-8.10.1046/j.1537-2995.1978.18579036386.x705863Search in Google Scholar

8Lacey P, Laird-Fryer B, Block U, Lair J, Guilbeau L, Moulds JJ. A new high incidence blood group factor, Sl^a, and its hypothetical allele (abstract). Transfusion 1980;20:632.Search in Google Scholar

9Molthan L. Expansion of the York, Cost, McCoy, Knops blood group system: the new McCoy antigens McC^c and McC^d. Med Lab Sci 1983;40:113-21.Search in Google Scholar

10Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3501-7.10.4049/jimmunol.146.10.3502Search in Google Scholar

11Wilson JG, Murphy EE, Wong WW, Klickstein LB, Weis JH, Fearon DT. Identification of a restriction fragment polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med 1986;164:50-9.10.1084/jem.164.1.5021881873014040Search in Google Scholar

12Cornillet P, Philbert F, Kazatchkine MD, Cohen JHM. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and Hind III restriction enzyme digestion. J Immunol Meth 1991;136:193-7.13. Moulds JM, Brai M, Cohen J, et al. Reference typing report for complement receptor 1 (CR1). Exp Clin Immunogenet 1998;15:291-4.10.1159/00001908410072640Search in Google Scholar

14Herrera AH, Xiang L, Martin SG, Lewis J, Wilson JG. Analysis of complement receptor type 1 (CR1) expression on erythrocytes and of CR1 allelic markers in Caucasian and African American populations. Clin Immunol Immunopathol 1998;87:176-83.10.1006/clin.1998.45299614933Search in Google Scholar

15Vik DP, Wong WW. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. J Immunol 1993;151:6214-24.10.4049/jimmunol.151.11.6214Search in Google Scholar

16Moulds JM, Zimmerman PA, Doumbo OK, et al. Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001;97:2879-85.10.1182/blood.V97.9.287911313284Search in Google Scholar

17Moulds JM, Zimmerman PA, Doumbo OK, et al. Expansion of the Knops blood group system and subdivision of Sl^a. Transfusion (in press: 2001).10.1046/j.1537-2995.2002.00002.x11896343Search in Google Scholar

18Rowe JA, Moulds JM, Newbold CI, Miller LH. P. falciparum rosetting mediated by a parasite-variant erythrocyte protein and complement-receptor 1. Nature 1997;388:292-5.10.1038/408889230440Search in Google Scholar

19Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun 1995;63:2323-6.10.1128/iai.63.6.2323-2326.19951733047768616Search in Google Scholar

20Moulds JM, Kassambara L, Middleton JJ, et al. Identification of complement receptor one (CR1) polymorphisms in West Africa. Genes and Immunity 2000;1:325-9.10.1038/sj.gene.636367611196694Search in Google Scholar

21Da Silva RP, Hall BF, Joiner KA, Sacks DL. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 1989;143:617-22.10.4049/jimmunol.143.2.617Search in Google Scholar

22Payne NR, Horwitz MA. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 1987;166: 1377-89.10.1084/jem.166.5.137721896473316470Search in Google Scholar

23Schlesinger LS, Horwitz MA. Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum. J Clin Invest 1990;85: 1304-14.10.1172/JCI1145682965672138634Search in Google Scholar

24Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990;144:2771-80.10.4049/jimmunol.144.7.2771Search in Google Scholar

25Miller WV. ed. Technical methods and procedures of the American Association of Blood Banks. Washington, DC: American Association of Blood Banks, 1974.Search in Google Scholar

26Molthan L. The serology of the York-Cost-McCoy-Knops red blood cell system. Am J Med Tech 1983;49:49-56.Search in Google Scholar

27Moulds JM, Moulds JJ, Brown MC, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/ Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992;62:230-5.Search in Google Scholar

28Pascual M, Lutz HU, Steiger G, Stammler P, Schifferli JA. Release of vesicles enriched in complement receptor 1 from human erythrocytes. J Immunol 1993;151:397-404.10.4049/jimmunol.151.1.397Search in Google Scholar

29Moulds JM, Brown LL. Loss of complement receptor one (CR1) from stored blood and its effect on Knops blood group reactivity. Immunohematology 1995;11:46-50.10.21307/immunohematology-2019-787Search in Google Scholar

30Moulds MK. Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies. Am J Med Tech 1981;10:789-95.Search in Google Scholar

31Reid ME, Lomas-Francis C. Knops blood group system. The blood group antigen factsbook. New York: Harcourt Brace & Company, 1997:332-41.10.1016/B978-012586585-2/50014-7Search in Google Scholar

32Daniels GL, Shaw MA, Lomas CG, Leak MR, Tippett P. The effect of In(Lu) on some high-frequency antigens. Transfusion 1986;26:171-2.10.1046/j.1537-2995.1986.26286152909.x3952792Search in Google Scholar

33Moulds JM, Shah C. Complement receptor 1 red cell expression is not controlled by the In(Lu) gene. Transfusion 1999;39:751-5.10.1046/j.1537-2995.1999.39070751.x10413284Search in Google Scholar

34Ferguson SJ, Blajchman MA, Guzewski H, Taylor CR, Moulds J. Alloantibody-induced impaired neonatal expression of a red blood cell antigen associated with maternal alloimmunization. Vox Sang 1982;43:82-6.10.1111/j.1423-0410.1982.tb00530.xSearch in Google Scholar

35Race RR, Sanger R. Some very frequent antigens. Blood groups in man. London: Blackwell Scientific Publications, 1975:410-30.Search in Google Scholar

36Pascual M, Steiger G, Sadallah S, et al. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994;179:889-99.10.1084/jem.179.3.88921914198113681Search in Google Scholar

37Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J Immunol 1985;134:3332-8.10.4049/jimmunol.134.5.3332Search in Google Scholar

38Danielsson C, Pascual M, Larsen B, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage. Eur J Immunol 1994;24:2725-31.10.1002/eji.18302411237957565Search in Google Scholar

39Pascual M, Duchosal MA, Steiger G, et al. Circulating soluble CR1 (CD35). J Immunol 1993;151:1702-11.10.4049/jimmunol.151.3.1702Search in Google Scholar

40Moulds JM, Rowe KE. Neutralization of Knops system antibodies using soluble complement receptor 1. Transfusion 1996;36:517-20.10.1046/j.1537-2995.1996.36696269510.x8669083Search in Google Scholar

41Molthan L. The status of the McCoy/Knops antigens. Med Lab Sci 1983;40:59-63.Search in Google Scholar